Ceramide glucosyltransferase | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
EC no. | 2.4.1.80 | ||||||||
CAS no. | 37237-44-8 | ||||||||
Databases | |||||||||
IntEnz | IntEnz view | ||||||||
BRENDA | BRENDA entry | ||||||||
ExPASy | NiceZyme view | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
|
Ceramide glucosyltransferase (orglucosylceramide synthase) is a glucosyltransferase enzyme involved in the production of glucocerebroside.[1]
It is classified under EC 2.4.1.80.
It is inhibited by miglustat and eliglustat, both drugs developed for the treatment of Gaucher disease.[citation needed]
| |||||||||
---|---|---|---|---|---|---|---|---|---|
Sphingolipid |
| ||||||||
NCL |
| ||||||||
Ceramide synthesis |
|
This transferase article is a stub. You can help Wikipedia by expanding it. |